The Biden administration and its supporters are working to ensure Americans are aware of how drug pricing reforms in the Inflation Reduction Act are expected to benefit demographics across the country, including women and Latinos that are disproportionately impacted by high health care costs, and the residents of multiple GOP-led states despite ongoing pushback against the IRA by Republican lawmakers. The outreach efforts come as CMS implements the IRA’s Medicare drug negotiation program amid lawsuits from the pharmaceutical industry. CMS...